Probiotic Consortium Confers Synergistic Anti-Inflammatory Effects in Inflammatory Disorders.

ABSTRACT: The composition and diversity of gut microbiota significantly influence the immune system and are linked to various diseases, including inflammatory and allergy disorders. While considerable research has focused on exploring single bacterial species or consortia, the optimal strategies for microbiota-based therapeutics remain underexplored. Specifically, the comparative effectiveness of bacterial consortia versus individual species warrants further investigation. In our study, we assessed the impact of the bacterial consortium MPRO, comprising Lactiplantibacillus plantarum HY7712, Bifidobacterium animalis ssp. lactis HY8002, and Lacticaseibacillus casei HY2782, in comparison to its individual components. The administration of MPRO demonstrated enhanced therapeutic effi

SUBMITTER: Lee C 

PROVIDER: S-EPMC10975258 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature